These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24885319)

  • 1. Diagnostic value of serum HE4 in endometrial cancer: a meta-analysis.
    Bie Y; Zhang Z
    World J Surg Oncol; 2014 May; 12():169. PubMed ID: 24885319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Human Epididymis Protein 4 Combined with Carbohydrate Antigen 125 for Endometrial Carcinoma Diagnosis: A Meta-Analysis and Systematic Review.
    Huang GQ; Xi YY; Zhang CJ; Jiang X
    Genet Test Mol Biomarkers; 2019 Aug; 23(8):580-588. PubMed ID: 31373853
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum human epididymis protein 4 vs. carbohydrate antigen 125 and their combination for endometrial cancer diagnosis: a meta-analysis.
    Chen Y; Ren YL; Li N; Yi XF; Wang HY
    Eur Rev Med Pharmacol Sci; 2016 May; 20(10):1974-85. PubMed ID: 27249595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of serum human epididymis protein 4 and CA125 on endometrial cancer detection: A meta-analysis.
    Li J; Wang X; Qu W; Wang J; Jiang SW
    Clin Chim Acta; 2019 Jan; 488():215-220. PubMed ID: 30414437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic value of human epididymis protein 4 for endometrial cancer is moderate.
    Liu J; Han L; Jiao Z
    Sci Rep; 2021 Jan; 11(1):575. PubMed ID: 33436780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of novel biomarker HE4 in endometrial cancer: a case control prospective study.
    Angioli R; Plotti F; Capriglione S; Montera R; Damiani P; Ricciardi R; Aloisi A; Luvero D; Cafà EV; Dugo N; Angelucci M; Benedetti-Panici P
    Tumour Biol; 2013 Feb; 34(1):571-6. PubMed ID: 23179397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of the diagnostic accuracy of HE4 for endometrial carcinoma.
    Liu J; Han L; Sun Q; Li Y; Niyazi M
    Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():404-411. PubMed ID: 32711295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does HE4 have a role as biomarker in the recurrence of ovarian cancer?
    Plotti F; Capriglione S; Terranova C; Montera R; Aloisi A; Damiani P; Muzii L; Scaletta G; Benedetti-Panici P; Angioli R
    Tumour Biol; 2012 Dec; 33(6):2117-23. PubMed ID: 22875782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical significance of DJ-1 and HE4 in patients with endometrial cancer.
    Benati M; Montagnana M; Danese E; Paviati E; Giudici S; Ruzzenente O; Franchi M; Lippi G
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Human Epididymis Protein 4 (HE4) in Determining Survival of Patients With Endometrial Cancer: A Meta-Analysis.
    He Y; Wang J; Ma CX; Kang YH
    Technol Cancer Res Treat; 2020; 19():1533033820971660. PubMed ID: 33148127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human epididymis protein 4 in endometrial cancer: A meta-analysis.
    Li LM; Zhu YX; Zhong Y; Su T; Fan XM; Xi Q; Li MY; Fu J; Tan H; Liu S
    Clin Chim Acta; 2018 Jul; 482():215-223. PubMed ID: 29630870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma.
    Quan Q; Liao Q; Yin W; Zhou S; Gong S; Mu X
    Sci Rep; 2021 Nov; 11(1):21694. PubMed ID: 34737393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical review on HE4 performance in endometrial cancer: where are we now?
    Angioli R; Miranda A; Aloisi A; Montera R; Capriglione S; De Cicco Nardone C; Terranova C; Plotti F
    Tumour Biol; 2014 Feb; 35(2):881-7. PubMed ID: 24068567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomas.
    Simmons AR; Baggerly K; Bast RC
    Oncology (Williston Park); 2013 Jun; 27(6):548-56. PubMed ID: 23909069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The importance of HE4 in differential diagnosis of endometrial cancer].
    Minář L; Klabenešová I; Jandáková E
    Ceska Gynekol; 2015 Aug; 80(4):256-63. PubMed ID: 26265413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of serum HE4 level in the management of endometrial cancer: A pilot study.
    Rajadevan N; McNally O; Neesham D; Richards A; Naaman Y
    Aust N Z J Obstet Gynaecol; 2021 Apr; 61(2):284-289. PubMed ID: 33528032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of serum HE4 as a prognostic marker in carcinoma of the ovary.
    Lakshmanan M; Kumar V; Chaturvedi A; Misra S; Gupta S; Akhtar N; Rajan S; Jain K; Garg S
    Indian J Cancer; 2019; 56(3):216-221. PubMed ID: 31389384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Risk Index Combining d-Dimer, Fibrinogen, HE4, and CA199 Differentiates Suspecting Endometrial Cancer From Patients With Abnormal Vaginal Bleeding or Discharge.
    Ge L; Liu G; Hu K; Huang K; Zhang M; Zhou J; Teng F; Cao J; Dai C; Jia X
    Technol Cancer Res Treat; 2020; 19():1533033819901117. PubMed ID: 32167027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic role of HE4 expression in multiple carcinomas: A protocol for systematic review and meta-analysis.
    Kumarasamy C; Madhav MR; Sabarimurugan S; Lakhotiya K; Pandey V; Priyadharshini T; Baxi S; Gothandam KM; Jayaraj R
    Medicine (Baltimore); 2019 Jul; 98(28):e15336. PubMed ID: 31305389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.
    Kalogera E; Scholler N; Powless C; Weaver A; Drapkin R; Li J; Jiang SW; Podratz K; Urban N; Dowdy SC
    Gynecol Oncol; 2012 Feb; 124(2):270-5. PubMed ID: 22037318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.